Pfizer withdraws sickle cell disease treatment from all markets-January 2024-www.financetom.com

Pfizer withdraws sickle cell disease treatment from all markets

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Pfizer withdraws sickle cell disease treatment from all markets

Sep 25, 2024 2:33 PM

Sept 25 (Reuters) - U.S. drugmaker Pfizer ( PFE ) said

on Wednesday it was voluntarily withdrawing all lots of its

therapy Oxbryta, used for the treatment of sickle cell disease,

in all markets where it is approved.

Previous page： Axis Mutual Fund eyes ₹3 lakh crore AUM by March, expects ₹2,500 crore from new fund Next page： Sula Vineyards expects bumper harvest in early 2024

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Axis Mutual Fund eyes ₹3 lakh crore AUM by March, expects ₹2,500 crore from new fund

Nov 29, 2023

The fund house opened the year with an AUM (assets under management) of over ₹2.25 lakh crore. The open-ended equity scheme represents the manufacturing theme and opens for subscription on December 1 and closes on December 15.

Sula Vineyards expects bumper harvest in early 2024

Nov 29, 2023

The unseasonal rainfall in Mumbai and other parts of the state prompted concerns about potential disruptions in the agricultural supply chain.

Cult US sneaker brand Foot Locker inks exclusive licensing deal with Metro Brands & Nykaa

Nov 29, 2023

The volume of the sneaker segment in India is projected to reach 66 million pairs by 2028. Shares of Metro Brands Ltd ended at ₹1,326.85, up by ₹27.10, or 2.09%, and shares of FSN E-Commerce Ventures Ltd ended at ₹172.10, up by ₹2.80, or 1.65%, on the BSE.

UltraTech Cement acquires Burnpur Cement's grinding assets in Jharkhand for ₹170 crore

Nov 29, 2023

This acquisition not only substantially hikes UltraTech Cement's capacity but also serves as a strategic entry into the promising market of Jharkhand. Shares of UltraTech Cement Ltd ended at ₹8,721.80, down by ₹6.20, or 0.071%, on the BSE.